Results of the Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound Study (AQUARIUS) reveal that the blood pressure lowering drug aliskiren did not improve coronary artery disease when given to patients who had prehypertension. The findings, reported at the European Society of Cardiology Congress with simultaneous publication in the iJournal of the American Medical Association/i, offer new insight into the value of lowering blood pressure ...You have just read an article categorized health
titled News from Late-Breaking Trials on Heart Failure and Acute Coronary Syndrome.
Written by:
editor - Thursday, September 5, 2013
There are currently no comments for "News from Late-Breaking Trials on Heart Failure and Acute Coronary Syndrome"
Post a Comment